This is consistent with prior data demonstrating that SCM has a matrix metalloproteinase (MMP)/tissue inhibitor of matrix metalloproteinase (TIMP) profile similar to hypertensive heart disease, which is distinct from AMI (26). This evidence concerns the gene TIMP1 and hypertensive heart disease.